Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
826.00    -23.00 (-2.71%)
Bid:
827.50
Ask:
830.00
Spread: 2.50 (0.302%)
Market Cap: £951.34m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

Kainos acquires IntuitiveTEK LLC

2 Mar 2020 07:00

RNS Number : 5897E
Kainos Group plc
02 March 2020
 

 

2 March 2020 

Kainos Group plc

("Kainos" or the "Company")

Kainos acquires IntuitiveTEK LLC

 

Kainos (LSE: KNOS), a leading UK-based provider of digital services and platforms, today announced the acquisition of Intuitive Technologies LLC ("IntuitiveTEK"), a trusted advisor in the areas of financial consolidation, budgeting, planning, forecasting, reporting and accounting solutions.

Founded in 2010 and headquartered in Denver, Colorado, IntuitiveTEK has a workforce of 38 and has completed more than 500 Adaptive Insights projects, with an aggregate of more than 150 years of dedicated Adaptive Insights consulting resources team experience. 

Adaptive Insights, a Workday company, powers a new generation of business planning. Workday helps businesses better plan, execute and analyse across the enterprise in one system.

Following the purchases of Formulate and Implexa at the end of 2019, which extended Kainos' Adaptive Insights capabilities in the UK and European markets, the acquisition of IntuitiveTEK makes Kainos one of the largest Adaptive Insights practices globally. The addition of IntuitiveTEK will also enable Kainos to accelerate the growth of its North America practice. 

The terms of the acquisition have not been disclosed.  

Commenting on the acquisition Brendan Mooney, CEO, Kainos, said: 

"I am delighted to welcome the IntuitiveTEK team to Kainos, and into our ever-expanding Workday practice. The team's expertise, excellent reputation, and passion for building strong customer relationships aligns with our business, and we look forward to having them on board. As a leading Workday partner, we see this acquisition as an important step to deepen our expertise in Adaptive Insights Business Planning Cloud in the United States, where we continue to see growing demand from clients in modernizing their planning and financial management processes."

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014. Prior to publication, certain information contained within this Announcement was deemed to constitute inside information for the purposes of Article 7 of MAR. 

 

ENDS

For further information, please contact: 

Kainos Group plc via FTI Consulting LLP 

Brendan Mooney, Chief Executive Officer 

Richard McCann, Chief Financial Officer 

 

Investec Bank plc +44 20 7597 5970 

Patrick Robb / Sebastian Lawrence 

 

Canaccord Genuity +44 20 7523 4606 

Simon Bridges/Andrew Potts 

 

FTI Consulting LLP +44 20 3727 1000 

Matt Dixon / Leah Dudley / Kwaku Aning

 

About Kainos 

Kainos Group plc is a UK-headquartered provider of Digital Services and Digital Platforms.

The Group's Digital Services include full lifecycle development and support of customised Digital Services for government and commercial customers. Kainos is also one of the leading European partner for Workday, Inc. ('Workday'), responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise and, now, government customers.

The Group's Digital Platforms comprise specialised digital platforms in the mobile healthcare and automated testing arenas. Smart is an automated testing platform for Workday customers; Evolve Electronic Medical Records ('EMR') is the market-leading product for the digitisation of patient notes in the Acute sector of the NHS. 

Kainos has over 1,550 people across 13 offices in Europe and North America.

Kainos is listed on the London Stock Exchange (LSE: KNOS). For further information, please visit www.kainos.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQUPUCPWUPUGMG
Date   Source Headline
8th Jun 20264:04 pmRNSNotification of Transactions of Director/PDMR
4th Jun 202611:31 amRNSDirector / PDMR shareholdings
1st Jun 202610:27 amRNSTotal Voting Rights
18th May 20267:00 amRNSFull Year Results
18th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
1st May 202611:06 amRNSTotal Voting Rights
28th Apr 20261:38 pmRNSBoard and Board Committee Changes
28th Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSYear-end Trading Update
14th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 202610:22 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20265:10 pmRNSDirector Declaration
24th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20263:16 pmRNSNotification of Major Holdings
17th Mar 202611:28 amRNSDirector/PDMR shareholdings
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20264:58 pmRNSNotification of Transactions of Director/PDMR
12th Mar 20262:13 pmRNSHolding(s) in Company
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20269:30 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20269:43 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.